Evidence map›Paper›PMID 24623598›Full record

ArticlePathogens and disease2014

High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.

Christopher G Pierce, Stephen P Saville, Jose L Lopez-Ribot

Open access · bronzeAbstract read
In one paragraph

Article in Pathogens and disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. The power of many: when genetics met yeasts and high-throughput.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mechanistic Understanding ofFrontiers in microbiology · 2021
    Review
  8. Intestinal Infection ofFrontiers in microbiology · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Assessment and Optimizations of Candida albicansAntimicrobial agents and chemotherapy · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Christopher G PierceDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX, USA.
Stephen P Saville
Jose L Lopez-Ribot
Texas Center for Infectious Disease · USThe University of Texas at San Antonio · US

Funding

NRG1 Regulated Genes in Candida albicans PathogenicityR01AI063256 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI SAVILLE, STEPHEN P · 2006 to 2009
$1.1M
Small molecule inhibitors of Candida albicans biofilm formationR21DE017294 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2007 to 2008
$376k
NIAID NIH HHS R01 AI063256NIAID NIH HHS R01AI063256NIDCR NIH HHS R21 DE017294NIDCR NIH HHS R21DE017294
6 · The paper itself

Abstract

Candida species represent the main cause of opportunistic fungal infections worldwide, and Candida albicans remains the most common etiological agent of candidiasis, now the third to fourth most common nosocomial infection. These infections are typically associated with high morbidity and mortality, mainly due to the limited efficacy of current antifungal drugs. In C. albicans, morphogenetic conversions between yeast and filamentous forms and biofilm formation represent two important biological processes that are intimately associated with the biology of this fungus and also play important roles during the pathogenesis of candidiasis. We have performed cell-based phenotypic screens using three different chemical libraries from the National Cancer Institute's Open Chemical Repository collection and identified several compounds with inhibitory activity against C. albicans biofilm formation and/or filamentation. These phenotype-based approaches represent a prosperous alternative to conventional genetics and genomics techniques to address experimentally challenging and complex biological phenomena, such as biofilm formation and filamentation, while at the same time opening new possibilities for the development of new antifungal agents.

Indexed as

High-Throughput Screening AssaysAntifungal AgentsBiofilmsCandida albicansDose-Response Relationship, DrugDrug Evaluation, PreclinicalHumansMicrobial Sensitivity TestsSmall Molecule LibrariesAntifungal AgentsSmall Molecule LibrariesbiofilmsCandida albicanschemical libraryfilamentationhigh-content screening

Identifiers

PMID24623598
PMCPMC3988658
OpenAlexW2033415590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.